Business in Brief: Strauss Recalls Hummus Over Salmonella Fear

Embattled Electra CEO resigns ■ Tel Aviv markets close flat ■ Competitors mixed over Super-Sol’s deal to end exclusivity

Strauss Hummus
סטודיו שטראוס

Strauss recalls hummus over salmonella fear

Strauss Group announced Tuesday the recall of one batch of its Achla brand prepared hummus due to possible salmonella contamination. After a routine test produced inconclusive results, a small number of containers were mistakenly delivered to retailers. The company said that only 650-gram containers of Achla hummus with the barcode 7290107940030 and expiration date of September 6, 2018 are affected and should not be eaten. The company has informed the Health Ministry and is trying to recall the suspected products from the shelves. “Strauss apologizes to its customers,” the company announced. “It is important to stress that all other products from the Achla line were tested and found to be totally fit for consumption.” The company added that inquires can be made to Strauss by phone, 1-800-777-777. (Hadar Kane)

Competitors mixed over Super-Sol’s deal to end exclusivity

The decision by Israel’s Antitrust Authority to end Super-Sol’s exclusive rights to sell food products in shopping centers drew mixed reactions from competitors. Small businesses are optimistic that the change will be real. In contrast, other supermarket chains, Super-Sol’s direct competitors, say the step is meaningless. “It’s an empty decision,” said a senior food retail executive Tuesday. “No mall will actually bring in another player.” According to Monday’s agreement, the supermarket chain will terminate all agreements giving it exclusive rights to sell food products in shopping centers and pay a fine of 8.9 million shekels ($2.4 million) for violating food law rules. (Hadar Kane)

Embattled Electra CEO resigns

After a 50% dive of his company’s shares and an investigation by the Israel Securities Authority, Electra Consumer Products CEO Zeev Kalimi announced Tuesday that he would resign in three months, as per an agreement he made last week with company chairman Danny Zalkind. Prior to his resignation, the state prosecutor decided to indict Kalimi for using insider information, subject to a hearing. Kalimi is charged with using insider information and insider trading of Osem Food shares worth 250,000 shekels ($68,150) before its merger with Nestle a number of years ago. Associates of Kalimi say his resignation has nothing to do with the state prosecutor’s decision. The ISA questioned Kalimi in January 2017 for several hours on suspicion of using insider information, after which he was released without restrictions. The authority submitted its findings to the prosecutor’s office this year. (Eran Azran)

Tel Aviv markets close flat

Shares on the Tel Aviv Stock Exchange were mostly stable Monday, as the TA-35 and TA-125 indexes both closed virtually unchanged at 1579.49 and 1407.97. Opko Health was one of the big winners, ending up 10.0%, while Biotime shares shot up 8.9%. Shares of Baran, which rose 11.1% Monday after announcing African development deals, climbed a further 4.7% to 7.84. RedHill Biopharma shares, in contrast, got pummeled a second straight day after announcing Monday a successful clinical trial for its Crohn’s disease drug, taking a 22.5% hit. Shares of Camtek dived 5.0% to 29.59 despite a rosy report that second-quarter revenue rose 34% to $4.3 million. Fattal Hotels got a 0.9% boost after getting a market outperform rating. In the Forex market, dollar lost a little ground to the shekel, ending down 0.1% to 3.664, while the euro strengthened to 4.300 euros per shekel. (Eran Azran)